Furthermore, “regulation of cell cycle” or “response to drug” descriptors of module 13 explained bladder cancer versus normal bladder tissue; this is consistent with current scientific reports where the drug resistance is dependent on the JUND representative of the Jun family [57, 58], which was a part of AP-2α target genes list forming module 13 along with two other Jun members. The gene discussed is JUN; the disease is urinary bladder carcinoma.